Short Peptides GPCR that Selectively Modulate Signal Transduction for vascular disorders (pro angiogenic molecules)

Ben-Sasson Shmuel, HUJI, School of Medicine - IMRIC, Developmental Biology and Cancer Research
Additional material on the technology can be supplied upon request

Patent Status

Published CN 105873944 A

Granted US 7,683,031; US 9,873,724

Contact for more information:

Ariela Markel
VP, Business Development, Healthcare
Contact ME:
All projects by:Ben-Sasson Shmuel (9)